首页> 外国专利> Apparatus and systems for verifying the efficacy of a drug and food acting on a target mechanism using artificial intelligence

Apparatus and systems for verifying the efficacy of a drug and food acting on a target mechanism using artificial intelligence

机译:用于验证药物和食物在使用人工智能的目标机制上作用的疗效的装置和系统

摘要

A method for verifying the effectiveness of a drug acting on a target gene using artificial intelligence is provided by one disclosure, and the method includes periodically acquiring medical data of patients who received a first drug prepared to cure a disease. Step, classifying treatment data of patients whose disease was cured after administration of the first drug into a first category and medical data of patients whose disease was not cured after administration of the first drug into a second category among medical data; Deriving a target gene from the genes of patients included in the first category by using the first artificial intelligence learning model that learned the relationship between the gene expression distribution and the gene expression distribution by the components of the first drug, in the second category Obtaining a biomarker profile by analyzing the expression state of the target gene and the expression state of other genes by the first drug from the gene expression information of the included patients, and the target gene and components of the first drug based on the biomarker profile and determining whether to administer the second drug and the content of the second drug that can be used to treat diseases of patients included in the second category by using the second artificial intelligence learning model that has learned the relationship with the content. may include
机译:通过一种公开内容提供了一种用于验证作用于靶基因对靶基因的药物的有效性的方法,并且该方法包括定期获取接受患有疾病的第一种药物的患者的医疗数据。步骤,将疾病在将第一种药物施用后固化的患者的治疗数据分类为疾病在将第一个药物施用到医疗数据中的第二类中未治愈的患者的第一类和医疗数据中;通过使用第一个人工智能学习模型从第一类中包括的患者中包括的患者的基因产生靶基因,该模型学习了第一种药物组分的基因表达分布与基因表达分布之间的关系,在第二类获取A.通过从包括患者的基因表达信息分析靶基因的表达状态和其他基因的表达状态和基于生物标志物剖面的靶基因和第一种药物的靶基因和组分,并确定是否为了通过使用已经学习与内容的关系的第二人工智能学习模型,施用第二种药物和第二种药物的含量,该药物可用于治疗第二类中包括的患者患者的疾病。可能包括

著录项

  • 公开/公告号KR102278528B1

    专利类型

  • 公开/公告日2021-07-16

    原文格式PDF

  • 申请/专利权人 주식회사 파미니티;

    申请/专利号KR20190071100

  • 发明设计人 김성수;이지원;노유헌;

    申请日2019-06-14

  • 分类号G16B25/10;G06N3;G16B50/20;G16H50/70;

  • 国家 KR

  • 入库时间 2022-08-24 20:23:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号